Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calyx Bio-Ventures, later rebranded as Calyx Ventures, was a Canadian-based company that initially operated within the agricultural biotechnology sector. Its primary focus was the commercialization of Brassica carinata, a non-food oilseed crop used for producing sustainable aviation fuel and biodiesel. Over time, the company pivoted its business strategy toward the burgeoning cannabis industry, developing a suite of technology assets including the LeafyThings platform. These digital solutions were designed to provide directory services, e-commerce capabilities, and social media engagement for cannabis consumers and retailers. In its final active stages, the company further diversified into blockchain technology and cryptocurrency mining operations. Headquartered in Vancouver, Calyx was publicly traded on the TSX Venture Exchange but has since faced regulatory cease-trade orders and delisting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calyx Bio-Ventures.